Camlin Fine Sciences Limited — QIP/Rights/Pref., 22-11-2024: Issue of Securities

Camlin Fine Sciences has announced a board meeting outcome that includes a revised rights issue amounting to up to ₹225 crore. Additionally, the company has approved the issuance of up to 10,000 senior, secured, redeemable, unlisted, unrated, non-convertible debentures (NCDs) with a face value of ₹1 lakh each, aggregating to ₹100 crore through private placement. The NCDs will carry an interest rate of 16% per annum, payable quarterly, with a maturity period of 13 months from the disbursement date.